Phibro Animal Health Corporation (NASDAQ:PAHC) is scheduled to be announcing its earnings results after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of $0.39 per share for the quarter. Phibro Animal Health Corporation has set its FY18 guidance at $1.55-1.61 EPS.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its earnings results on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.04. The firm had revenue of $194.84 million for the quarter, compared to analyst estimates of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.32 EPS. On average, analysts expect Phibro Animal Health Corporation to post $1.57 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded down 1.20% during midday trading on Monday, hitting $37.10. 6,791 shares of the stock were exchanged. Phibro Animal Health Corporation has a 12 month low of $24.85 and a 12 month high of $40.25. The stock has a market cap of $1.48 billion, a P/E ratio of 23.04 and a beta of 1.37. The firm has a 50 day moving average of $36.76 and a 200-day moving average of $35.75.

Several brokerages have issued reports on PAHC. Piper Jaffray Companies set a $41.00 target price on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a report on Friday, October 6th. Credit Suisse Group increased their target price on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a report on Thursday, August 31st. Bank of America Corporation reiterated an “underperform” rating and set a $33.00 target price on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. Finally, BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. Phibro Animal Health Corporation presently has a consensus rating of “Hold” and a consensus price target of $33.00.

TRADEMARK VIOLATION WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/30/phibro-animal-health-corporation-pahc-set-to-announce-quarterly-earnings-on-monday.html.

In other news, CFO Richard G. Johnson sold 55,529 shares of the firm’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $36.30, for a total value of $2,015,702.70. Following the sale, the chief financial officer now directly owns 15,900 shares in the company, valued at approximately $577,170. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Richard G. Johnson sold 29,807 shares of the firm’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $35.66, for a total transaction of $1,062,917.62. Following the completion of the sale, the chief financial officer now owns 4,240 shares in the company, valued at $151,198.40. The disclosure for this sale can be found here. Insiders sold a total of 292,448 shares of company stock worth $10,624,994 over the last 90 days. Company insiders own 51.88% of the company’s stock.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Earnings History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.